Somnox, with its ambitious slogan "Helping 100 million people rest better," is on a mission to revolutionize sleep health worldwide. Founded in 2016, the company merges robotics with consumer health, creating innovative solutions for stress and anxiety-induced sleep issues. At the forefront of their offerings is a patented technology that acts as a "breathing companion," leveraging biofeedback and breathwork to promote restful sleep.
The brainchild of CEO and co-founder Julian Jagtenberg, Somnox emerged from research conducted at the University of Technology Delft in The Netherlands. The company has won significant recognition, evidenced by awards such as the Red Dot Design award and the iF Design award. Positioned at the nexus of Health Care and Consumer Electronics, Somnox represents a compelling prospect in the market.
Somnox has most recently received a grant investment dated 14 June 2023, backed by the European Union and Den Haag. This support underscores confidence in Somnox's vision and potential for substantial market impact.